IBDEI04G ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5581,0)
 ;;=99071^^41^422^2^^^^1
 ;;^UTILITY(U,$J,358.3,5581,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5581,1,2,0)
 ;;=2^99071
 ;;^UTILITY(U,$J,358.3,5581,1,3,0)
 ;;=3^PATIENT EDUCATION MATERIALS
 ;;^UTILITY(U,$J,358.3,5582,0)
 ;;=0505F^^41^423^1^^^^1
 ;;^UTILITY(U,$J,358.3,5582,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5582,1,2,0)
 ;;=2^0505F
 ;;^UTILITY(U,$J,358.3,5582,1,3,0)
 ;;=3^HEMODIALYSIS PLAN DOCD
 ;;^UTILITY(U,$J,358.3,5583,0)
 ;;=B4164^^41^424^7^^^^1
 ;;^UTILITY(U,$J,358.3,5583,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5583,1,2,0)
 ;;=2^B4164
 ;;^UTILITY(U,$J,358.3,5583,1,3,0)
 ;;=3^ENTERAL FORMULA, CAT IV
 ;;^UTILITY(U,$J,358.3,5584,0)
 ;;=A4730^^41^424^8^^^^1
 ;;^UTILITY(U,$J,358.3,5584,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5584,1,2,0)
 ;;=2^A4730
 ;;^UTILITY(U,$J,358.3,5584,1,3,0)
 ;;=3^FISTULA CANNULATION SET, EA
 ;;^UTILITY(U,$J,358.3,5585,0)
 ;;=B5000^^41^424^10^^^^1
 ;;^UTILITY(U,$J,358.3,5585,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5585,1,2,0)
 ;;=2^B5000
 ;;^UTILITY(U,$J,358.3,5585,1,3,0)
 ;;=3^PARENT NUT SOL,ANY STRTH,RENAL
 ;;^UTILITY(U,$J,358.3,5586,0)
 ;;=A4714^^41^424^12^^^^1
 ;;^UTILITY(U,$J,358.3,5586,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5586,1,2,0)
 ;;=2^A4714
 ;;^UTILITY(U,$J,358.3,5586,1,3,0)
 ;;=3^TREATED WATER PER GALLON
 ;;^UTILITY(U,$J,358.3,5587,0)
 ;;=C1752^^41^424^5^^^^1
 ;;^UTILITY(U,$J,358.3,5587,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5587,1,2,0)
 ;;=2^C1752
 ;;^UTILITY(U,$J,358.3,5587,1,3,0)
 ;;=3^CATH,HEMODIALYSIS,SHORT-TERM
 ;;^UTILITY(U,$J,358.3,5588,0)
 ;;=C1750^^41^424^4^^^^1
 ;;^UTILITY(U,$J,358.3,5588,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5588,1,2,0)
 ;;=2^C1750
 ;;^UTILITY(U,$J,358.3,5588,1,3,0)
 ;;=3^CATH, HEMODIALYSIS,LONG-TERM
 ;;^UTILITY(U,$J,358.3,5589,0)
 ;;=85302^^41^424^3^^^^1
 ;;^UTILITY(U,$J,358.3,5589,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5589,1,2,0)
 ;;=2^85302
 ;;^UTILITY(U,$J,358.3,5589,1,3,0)
 ;;=3^BLOOD CLOT INHIBITOR ANTIGEN
 ;;^UTILITY(U,$J,358.3,5590,0)
 ;;=99070^^41^424^2^^^^1
 ;;^UTILITY(U,$J,358.3,5590,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5590,1,2,0)
 ;;=2^99070
 ;;^UTILITY(U,$J,358.3,5590,1,3,0)
 ;;=3^AV FISTULA KIT
 ;;^UTILITY(U,$J,358.3,5591,0)
 ;;=A9900^^41^424^11^^^^1
 ;;^UTILITY(U,$J,358.3,5591,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5591,1,2,0)
 ;;=2^A9900
 ;;^UTILITY(U,$J,358.3,5591,1,3,0)
 ;;=3^SUPPLY/ACCESSORY/SERVICE
 ;;^UTILITY(U,$J,358.3,5592,0)
 ;;=A4690^^41^424^6^^^^1
 ;;^UTILITY(U,$J,358.3,5592,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5592,1,2,0)
 ;;=2^A4690
 ;;^UTILITY(U,$J,358.3,5592,1,3,0)
 ;;=3^DIALYZER, EACH
 ;;^UTILITY(U,$J,358.3,5593,0)
 ;;=A4750^^41^424^1^^^^1
 ;;^UTILITY(U,$J,358.3,5593,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5593,1,2,0)
 ;;=2^A4750
 ;;^UTILITY(U,$J,358.3,5593,1,3,0)
 ;;=3^ART OR VENOUS BLOOD TUBING
 ;;^UTILITY(U,$J,358.3,5594,0)
 ;;=E1590^^41^424^9^^^^1
 ;;^UTILITY(U,$J,358.3,5594,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5594,1,2,0)
 ;;=2^E1590
 ;;^UTILITY(U,$J,358.3,5594,1,3,0)
 ;;=3^HEMODIALYSIS MACHINE
 ;;^UTILITY(U,$J,358.3,5595,0)
 ;;=90371^^41^425^3^^^^1
 ;;^UTILITY(U,$J,358.3,5595,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5595,1,2,0)
 ;;=2^90371
 ;;^UTILITY(U,$J,358.3,5595,1,3,0)
 ;;=3^HEP B IG IM
 ;;^UTILITY(U,$J,358.3,5596,0)
 ;;=90740^^41^425^4^^^^1
 ;;^UTILITY(U,$J,358.3,5596,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5596,1,2,0)
 ;;=2^90740
 ;;^UTILITY(U,$J,358.3,5596,1,3,0)
 ;;=3^HEPB VACC ILL PAT 3 DOSE IM
 ;;^UTILITY(U,$J,358.3,5597,0)
 ;;=90632^^41^425^2^^^^1
 ;;^UTILITY(U,$J,358.3,5597,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5597,1,2,0)
 ;;=2^90632
 ;;^UTILITY(U,$J,358.3,5597,1,3,0)
 ;;=3^HEP A VACCINE ADULT IM
 ;;^UTILITY(U,$J,358.3,5598,0)
 ;;=90703^^41^425^7^^^^1
 ;;^UTILITY(U,$J,358.3,5598,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5598,1,2,0)
 ;;=2^90703
 ;;^UTILITY(U,$J,358.3,5598,1,3,0)
 ;;=3^TETANUS VACCINE IM
 ;;^UTILITY(U,$J,358.3,5599,0)
 ;;=90732^^41^425^5^^^^1
 ;;^UTILITY(U,$J,358.3,5599,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5599,1,2,0)
 ;;=2^90732
 ;;^UTILITY(U,$J,358.3,5599,1,3,0)
 ;;=3^PNEUMOCOCCAL VACCINE
 ;;^UTILITY(U,$J,358.3,5600,0)
 ;;=86580^^41^425^6^^^^1
 ;;^UTILITY(U,$J,358.3,5600,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5600,1,2,0)
 ;;=2^86580
 ;;^UTILITY(U,$J,358.3,5600,1,3,0)
 ;;=3^TB INTRADERMAL TEST
 ;;^UTILITY(U,$J,358.3,5601,0)
 ;;=90658^^41^425^1^^^^1
 ;;^UTILITY(U,$J,358.3,5601,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5601,1,2,0)
 ;;=2^90658
 ;;^UTILITY(U,$J,358.3,5601,1,3,0)
 ;;=3^FLU VACCINE
 ;;^UTILITY(U,$J,358.3,5602,0)
 ;;=99241^^42^426^1
 ;;^UTILITY(U,$J,358.3,5602,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5602,1,1,0)
 ;;=1^Chart Consult
 ;;^UTILITY(U,$J,358.3,5602,1,2,0)
 ;;=2^99241
 ;;^UTILITY(U,$J,358.3,5603,0)
 ;;=99499^^42^427^1
 ;;^UTILITY(U,$J,358.3,5603,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5603,1,1,0)
 ;;=1^Chart Consult
 ;;^UTILITY(U,$J,358.3,5603,1,2,0)
 ;;=2^99499
 ;;^UTILITY(U,$J,358.3,5604,0)
 ;;=414.01^^43^428^7
 ;;^UTILITY(U,$J,358.3,5604,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5604,1,4,0)
 ;;=4^414.01
 ;;^UTILITY(U,$J,358.3,5604,1,5,0)
 ;;=5^Atherosclerosis, native coronary
 ;;^UTILITY(U,$J,358.3,5604,2)
 ;;=CAD, Native Vessel^303281
 ;;^UTILITY(U,$J,358.3,5605,0)
 ;;=V58.61^^43^428^3
 ;;^UTILITY(U,$J,358.3,5605,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5605,1,4,0)
 ;;=4^V58.61
 ;;^UTILITY(U,$J,358.3,5605,1,5,0)
 ;;=5^Anticoag Rx, chronic
 ;;^UTILITY(U,$J,358.3,5605,2)
 ;;=^303459
 ;;^UTILITY(U,$J,358.3,5606,0)
 ;;=428.0^^43^428^10
 ;;^UTILITY(U,$J,358.3,5606,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5606,1,4,0)
 ;;=4^428.0
 ;;^UTILITY(U,$J,358.3,5606,1,5,0)
 ;;=5^CHF
 ;;^UTILITY(U,$J,358.3,5606,2)
 ;;=^54758
 ;;^UTILITY(U,$J,358.3,5607,0)
 ;;=785.2^^43^428^32
 ;;^UTILITY(U,$J,358.3,5607,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5607,1,4,0)
 ;;=4^785.2
 ;;^UTILITY(U,$J,358.3,5607,1,5,0)
 ;;=5^Undiag Cardiac murmurs
 ;;^UTILITY(U,$J,358.3,5607,2)
 ;;=^295854
 ;;^UTILITY(U,$J,358.3,5608,0)
 ;;=412.^^43^428^28
 ;;^UTILITY(U,$J,358.3,5608,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5608,1,4,0)
 ;;=4^412.
 ;;^UTILITY(U,$J,358.3,5608,1,5,0)
 ;;=5^Past MI
 ;;^UTILITY(U,$J,358.3,5608,2)
 ;;=Past MI^259884
 ;;^UTILITY(U,$J,358.3,5609,0)
 ;;=443.9^^43^428^25
 ;;^UTILITY(U,$J,358.3,5609,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5609,1,4,0)
 ;;=4^443.9
 ;;^UTILITY(U,$J,358.3,5609,1,5,0)
 ;;=5^PVD
 ;;^UTILITY(U,$J,358.3,5609,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,5610,0)
 ;;=427.31^^43^428^8
 ;;^UTILITY(U,$J,358.3,5610,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5610,1,4,0)
 ;;=4^427.31
 ;;^UTILITY(U,$J,358.3,5610,1,5,0)
 ;;=5^Atrial Fibrillation
 ;;^UTILITY(U,$J,358.3,5610,2)
 ;;=^11378
 ;;^UTILITY(U,$J,358.3,5611,0)
 ;;=427.0^^43^428^27
 ;;^UTILITY(U,$J,358.3,5611,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5611,1,4,0)
 ;;=4^427.0
 ;;^UTILITY(U,$J,358.3,5611,1,5,0)
 ;;=5^Paroxysmal Supravent Tachycardia
 ;;^UTILITY(U,$J,358.3,5611,2)
 ;;=^90479
 ;;^UTILITY(U,$J,358.3,5612,0)
 ;;=785.1^^43^428^26
 ;;^UTILITY(U,$J,358.3,5612,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5612,1,4,0)
 ;;=4^785.1
 ;;^UTILITY(U,$J,358.3,5612,1,5,0)
 ;;=5^Palpitations
 ;;^UTILITY(U,$J,358.3,5612,2)
 ;;=Palpitations^89281
 ;;^UTILITY(U,$J,358.3,5613,0)
 ;;=424.1^^43^428^4
 ;;^UTILITY(U,$J,358.3,5613,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5613,1,4,0)
 ;;=4^424.1
 ;;^UTILITY(U,$J,358.3,5613,1,5,0)
 ;;=5^Aortic Stenosis
 ;;^UTILITY(U,$J,358.3,5613,2)
 ;;=Aortic Stenosis^9330
 ;;^UTILITY(U,$J,358.3,5614,0)
 ;;=424.0^^43^428^23
 ;;^UTILITY(U,$J,358.3,5614,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5614,1,4,0)
 ;;=4^424.0
 ;;^UTILITY(U,$J,358.3,5614,1,5,0)
 ;;=5^Mitral Valve Prolapse
 ;;^UTILITY(U,$J,358.3,5614,2)
 ;;=^78367
 ;;^UTILITY(U,$J,358.3,5615,0)
 ;;=424.90^^43^428^34
 ;;^UTILITY(U,$J,358.3,5615,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5615,1,4,0)
 ;;=4^424.90
 ;;^UTILITY(U,$J,358.3,5615,1,5,0)
 ;;=5^Valvular Heart Disease
 ;;^UTILITY(U,$J,358.3,5615,2)
 ;;=^40327
 ;;^UTILITY(U,$J,358.3,5616,0)
 ;;=401.1^^43^428^17
 ;;^UTILITY(U,$J,358.3,5616,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5616,1,4,0)
 ;;=4^401.1
 ;;^UTILITY(U,$J,358.3,5616,1,5,0)
 ;;=5^Hypertension, Benign
 ;;^UTILITY(U,$J,358.3,5616,2)
 ;;=^269591
 ;;^UTILITY(U,$J,358.3,5617,0)
 ;;=401.9^^43^428^18
 ;;^UTILITY(U,$J,358.3,5617,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5617,1,4,0)
 ;;=4^401.9
 ;;^UTILITY(U,$J,358.3,5617,1,5,0)
 ;;=5^Hypertension, Essential
 ;;^UTILITY(U,$J,358.3,5617,2)
 ;;=^186630
 ;;^UTILITY(U,$J,358.3,5618,0)
 ;;=427.9^^43^428^5
 ;;^UTILITY(U,$J,358.3,5618,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5618,1,4,0)
 ;;=4^427.9
 ;;^UTILITY(U,$J,358.3,5618,1,5,0)
 ;;=5^Arrhythmia NOS
 ;;^UTILITY(U,$J,358.3,5618,2)
 ;;=^10166
 ;;^UTILITY(U,$J,358.3,5619,0)
 ;;=398.90^^43^428^30
 ;;^UTILITY(U,$J,358.3,5619,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5619,1,4,0)
 ;;=4^398.90
 ;;^UTILITY(U,$J,358.3,5619,1,5,0)
 ;;=5^Rheumatic Heart Dis NOS
 ;;^UTILITY(U,$J,358.3,5619,2)
 ;;=^106006
 ;;^UTILITY(U,$J,358.3,5620,0)
 ;;=410.91^^43^428^22
 ;;^UTILITY(U,$J,358.3,5620,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5620,1,4,0)
 ;;=4^410.91
 ;;^UTILITY(U,$J,358.3,5620,1,5,0)
 ;;=5^MI,AC NOS <8 wks
 ;;^UTILITY(U,$J,358.3,5620,2)
 ;;=^269674
 ;;^UTILITY(U,$J,358.3,5621,0)
 ;;=410.91^^43^428^21
 ;;^UTILITY(U,$J,358.3,5621,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5621,1,4,0)
 ;;=4^410.91
 ;;^UTILITY(U,$J,358.3,5621,1,5,0)
 ;;=5^MI,AC Initial
 ;;^UTILITY(U,$J,358.3,5621,2)
 ;;=^269674
 ;;^UTILITY(U,$J,358.3,5622,0)
 ;;=410.92^^43^428^19
 ;;^UTILITY(U,$J,358.3,5622,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5622,1,4,0)
 ;;=4^410.92
 ;;^UTILITY(U,$J,358.3,5622,1,5,0)
 ;;=5^MI <8 wks,Subseq
 ;;^UTILITY(U,$J,358.3,5622,2)
 ;;=^269675
